Dynamische Erfassung multipler Expositionen gegenüber urbanen Umweltbelastungen

Das weltweite Bevölkerungswachstum und die fortschreitende Verstädterung führen zu einer Zunahme des Stadtverkehrs. Parallel dazu wirkt sich der Klimawandel negativ auf urbane Räume aus. Dadurch treten urbane Umweltbelastungen häufiger, länger und intensiver auf. Konsekutiv verstärken sich die negativen Auswirkungen multipler Umweltbelastungen wie Lärm, Feinstaub und Hitzebelastung auf die Stadtbewohner. Die Beobachtung und Analyse dieser Auswirkungen und die Umsetzung entsprechender Schutz- und Anpassungsmaßnahmen nehmen einen immer größeren Stellenwert in der umweltbezogenen Stadtforschung ein. Eine dafür notwendige Bestimmung der individuellen Exposition gegenüber urbanen Umweltbelastungen wird bisher jedoch vernachlässigt, da derzeitige Methoden auf stationären Messungen oder Modellierungen beruhen. Damit kann keine zufriedenstellende Bewertung einer individuellen Exposition erfolgen, welche durch die alltägliche Mobilität der Stadtbewohner zeitlich und räumlich variiert. Die Erhebung der individuellen Belastung ist jedoch sowohl für kurzfristige Anpassungsmaßnahmen relevant, als auch für langfristige Untersuchungen von umweltbedingten Gesundheitseffekten essentiell. Um dieses Problem zu lösen, wurden jedoch erst in den letzten Jahren empirische Methoden entwickelt. Um zudem das Bewusstsein und die Anpassungsmotivation von exponierten Personen zu verstehen, muss nicht nur die objektive Expositionsintensität bekannt sein, sondern auch die subjektiv wahrgenommene Belastung. Smartphone-basierte Methoden ermöglichen die Integration beider Perspektiven. In dieser Arbeit wird deshalb ein dynamischer Messansatz entwickelt, der anhand einer explorativen Studie mit Fahrradfahrern evaluiert wird. Daraus werden Implikationen für eine geographische Expositionsforschung abgeleitet

Genomic Indexing by Somatic Gene Recombination of mRNA/ncRNA – Does It Play a Role in Genomic Mosaicism, Memory Formation, and Alzheimer’s Disease?

Recent evidence indicates that genomic individuality of neurons, characterized by DNA-content variation, is a common if not universal phenomenon in the human brain that occurs naturally but can also show aberrancies that have been linked to the pathomechanism of Alzheimer’s disease and related neurodegenerative disorders. Etiologically, this genomic mosaic has been suggested to arise from defects of cell cycle regulation that may occur either during brain development or in the mature brain after terminal differentiation of neurons. Here, we aim to draw attention towards another mechanism that can give rise to genomic individuality of neurons, with far reaching consequences. This mechanism has its origin in the transcriptome rather than in replication defects of the genome, i.e., somatic gene recombination of RNA. We continue to develop the concept that somatic gene recombination of RNA provides a physiological process that, through integration of intronless mRNA/ncRNA into the genome, allows a particular functional state at the level of the individual neuron to be indexed. By insertion of defined RNAs in a somatic recombination process, the presence of specific mRNA transcripts within a definite temporal context can be “frozen” and can serve as an index that can be recalled at any later point in time. This allows information related to a specific neuronal state of differentiation and/or activity relevant to a memory trace to be fixed. We suggest that this process is used throughout the lifetime of each neuron and might have both advantageous and deleterious consequences

Improved Sensitivity of Allergen Detection by Immunoaffinity LC-MS/MS Using Ovalbumin as a Case Study

Vitamin D deficiency due to, e.g., nutritional and life style reasons is a health concern that is gaining increasing attention over the last two decades. Vitamin D3, the most common isoform of vitamin D, is only available in food derived from animal sources. However, mushrooms and yeast are rich in ergosterol. This compound can be converted into vitamin D2 by UV-light, and therefore act as a precursor for vitamin D. Vitamin D2 from UV-irradiated mushrooms has become an alternative source of vitamin D, especially for persons pursuing a vegan diet. UV-irradiated baker’s yeast (Saccharomyces cerevisiae) for the production of fortified yeast-leavened bread and baked goods was approved as a Novel Food Ingredient in the European Union, according to Regulation (EC) No. 258/97. The Scientific Opinion provided by the European Food Safety Authority Panel on Dietetic Products, Nutrition, and Allergies has assessed this Novel Food Ingredient as safe under the intended nutritional use. However, recent findings on the formation of side products during UV-irradiation, e.g., the photoproducts tachysterol and lumisterol which are compounds with no adequate risk assessment performed, have only been marginally considered for this EFSA opinion. Furthermore, proceedings in analytics can provide additional insights, which might open up new perspectives, also regarding the bioavailability and potential health benefits of vitamin D-fortified mushrooms and yeast. Therefore, this review is intended to give an overview on the current status of UV irradiation in mushrooms and yeast in general and provide a detailed assessment on the potential health effects of UV-irradiated baker’s yeast

Management of Urban Stormwater at Block-Level (MUST-B): A New Approach for Potential Analysis of Decentralized Stormwater Management Systems

Cities worldwide are facing problems to mitigate the impact of urban stormwater runoff caused by the increasing occurrence of heavy rainfall events and urban re-densification. This study presents a new approach for estimating the potential of the Management of Urban STormwater at Block-level (MUST-B) by decentralized blue-green infrastructures here called low-impact developments (LIDs) for already existing urban environments. The MUST-B method was applied to a study area in the northern part of the City of Leipzig, Germany. The Study areas was divided into blocks smallest functional units and considering two different soil permeability and three different rainfall events, seven scenarios have been developed: current situation, surface infiltration, swale infiltration, trench infiltration, trough-trench infiltration, and three different combinations of extensive roof greening, trough-trench infiltration, and shaft infiltration. The LIDs have been simulated and their maximum retention/infiltration potential and the required area have been estimated together with a cost calculation. The results showed that even stormwater of a 100 year rainfall event can be fully retained and infiltrated within the blocks on a soil with low permeability (kf = 10−6 m/s). The cost and the required area for the LIDs differed depending on the scenario and responded to the soil permeability and rainfall events. It is shown that the MUST-B method allows a simple down- and up-scaling process for different urban settings and facilitates decision making for implementing decentralized blue-green-infrastructure that retain, store, and infiltrate stormwater at block level

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease

Alzheimer's disease (AD) is the most common form of dementia clinically characterized by progressive impairment of memory and other cognitive functions. Many genetic researches in AD identified one common genetic variant (ε4) in Apolipoprotein E (APOE) gene as a risk factor for the disease. Two independent genome-wide studies demonstrated a new locus on chromosome 9p21.3 implicated in Late-Onset Alzheimer's Disease (LOAD) susceptibility in Caucasians. In the present study, we investigated the role of three SNP's in the CDKN2A gene (rs15515, rs3731246, and rs3731211) and one in the CDKN2B gene (rs598664) located in 9p21.3 using an association case-control study carried out in a group of Caucasian subjects including 238 LOAD cases and 250 controls. The role of CDKN2A and CDKN2B genetic variants in AD is not confirmed in our LOAD patients, and further studies are needed to elucidate the role of these genes in the susceptibility of AD

Case Report: Four cases of cardiac sarcoidosis in patients with inherited cardiomyopathy—a phenotypic overlap, co-existence of two rare cardiomyopathies or a second-hit disease

Cardiac sarcoidosis (CS), a rare condition characterized by non-caseating granulomas, can manifest with symptoms such as atrioventricular block and ventricular tachycardia (VT), as well as mimic inherited cardiomyopathies. A 48-year-old male presented with recurrent VT. The initial 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) scan showed uptake of the mediastinal lymph node. Cardiovascular magnetic resonance (CMR) demonstrated intramyocardial fibrosis. The follow-up 18FDG-PET scan revealed the presence of tracer uptake in the left ventricular (LV) septum, suggesting the likelihood of CS. Genetic testing identified a pathogenic LMNA variant. A 47-year-old female presented with complaints of palpitations and syncope. An Ajmaline provocation test confirmed Brugada syndrome (BrS). CMR revealed signs of cardiac inflammation. An endomyocardial biopsy (EMB) confirmed the diagnosis of cardiac sarcoidosis. Polymorphic VT was induced during an electrophysiological study, and an implantable cardioverter-defibrillator (ICD) was implanted. A 58-year-old woman presented with sustained VT with a prior diagnosis of hypertrophic cardiomyopathy (HCM). A genetic work-up identified the presence of a heterozygous MYBC3 variant of unknown significance (VUS). CMR revealed late gadolinium enhancement (LGE), while the 18FDG-PET scan demonstrated LV tracer uptake. The immunosuppressive therapy was adjusted, and no further VTs were observed. A 28-year-old male athlete with right ventricular dilatation and syncope experienced a cardiac arrest during training. Genetic testing identified a pathogenic mutation in PKP2. The autopsy has confirmed the presence of ACM and a distinctive extracardiac sarcoidosis. Cardiac sarcoidosis and inherited cardiomyopathies may interact in several different ways, altering the clinical presentation. Overlapping pathologies are frequently overlooked. Delayed or incomplete diagnosis risks inadequate treatment. Thus, genetic testing and endomyocardial biopsies should be recommended to obtain a clear diagnosis